Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPI | P09923 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | XIAP | P98170 | 1/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.39 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.36 |
| ▸ | LTA4H | P09960 | 2/20 | 0.36 |
| ▸ | ANPEP | P15144 | 2/20 | 0.36 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.36 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MME | P08473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylalanine SCHEMBL7686784 | 0.91 | SLC7A5 (0.52) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL3155213 | 0.91 | ALPI (0.46) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Dl-Phenylalanine SCHEMBL22559546 | 0.89 | SLC7A5 (0.50) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Histidine SCHEMBL7686781 | 0.85 | SLC7A5 (0.46) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Tyrosine SCHEMBL16540106 | 0.85 | SLC7A5 (0.38) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Phenylalanine SCHEMBL8904329 | 0.83 | SLC7A5 (0.56) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Dl-Phenylalanine SCHEMBL23580654 | 0.83 | SLC7A5 (0.43) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Histidine SCHEMBL28805947 | 0.82 | SLC7A5 (0.40) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Histidine SCHEMBL6426901 | 0.82 | SLC7A5 (0.40) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Histidine SCHEMBL668807 | 0.82 | SLC7A5 (0.40) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0644937-A4 | THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON NEUROTROPHIN-4 EXPRESSION. | — | 1995-05-03 | — | — | EP | disclosed |
| EP-0587806-A4 | THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON NEUROTROPHIN-4 EXPRESSION. | REGENERON PHARMA (US) | 1995-04-26 | — | — | EP | disclosed |
| EP-0644937-A1 | THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON NEUROTROPHIN-4 EXPRESSION | REGENERON PHARMACEUTICALS, INC. (US) | 1995-03-29 | — | — | EP | disclosed |
| EP-0587806-A1 | THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON NEUROTROPHIN-4 EXPRESSION | REGENERON PHARMACEUTICALS, INC. (US) | 1994-03-23 | — | — | EP | disclosed |
| WO-1993025684-A1 | THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON NEUROTROPHIN-4 EXPRESSION | REGENERON PHARMACEUTICALS, INC. (US) | 1993-12-23 | — | — | WO | disclosed |
| WO-1992020365-A1 | THERAPEUTIC AND DIAGNOSTIC METHODS BASED ON NEUROTROPHIN-4 EXPRESSION | REGENERON PHARMACEUTICALS, INC. (US) | 1992-11-26 | — | — | WO | disclosed |